5th International Caparica Conference in SPLICING 2023

17th – 20th July 2023 | Caparica | Portugal

Oral Speakers

Perry Howard, PhD

University of Victoria, Victoria (Canada)

Understanding the role of ARS2 in RNA processing: from the nucleus to the cytoplasm

Maria L. Spletter, PhD

University of Missouri Kansas City, Kansas City (USA)

Erzsebet Fekete, PhD

University of Debrecen, Debrecen (Hungary)

Spliceosomal twin introns (“stwintrons”) in fungi: structure, distribution and evolution

Tongsen Zheng, PhD

Director of GI Medical Oncology Department & Phase I Trials Center Harbin, Heilongjiang (China)

pmSTING: A novel STING isoform embedded within the cytomembrane sensing extracellular cGAMP directly

Katrina Lappin, PhD

Queen’s University Belfast, Belfast (Northern Ireland)

The relationship between spliceosome mutations and immune activation in cance

Michela A. Denti, PhD

Department of Cellular, Computational and Integrative Biology (CIBIO) University of Trento, Trento (Italy)

Exon Skipping Through Chimeric Antisense >U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect

Yunlong Liu, PhD

Indiana University School of Medicine, Indianopolis (USA)

Roles of Alternative Splicing in Substance Use Disorder

Sabine Müller, PhD

Universität Greifswald, Institut für Biochemie, Greifswald (Germany)

RNA splicing by small engineered ribozymes

Lisa Müller, PhD

Institute of Virology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf (Germany)

Modeling intrinsic splice site strength: Effects of SREs on HIV gene expression

Martin Schroeder, PhD

Department of Biosciences Durham University, Durham (UK)

RNA splicing in the unfolded protein response

Ya-Xiong Tao, PhD

Department of Anatomy, Physiology & Pharmacology, Auburn University, Auburn (USA)

Splicing variants of melanocortin-2 receptor accessory proteins

Xianquan Zhan, PhD

Shandong First Medical University, Shandong (China)

Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine

Liliana Florea, PhD

Johns Hopkins School of Medicine, Baltimore (USA)

Methods for differential splicing detection

Maria Costa, PhD

Institute for Integrative Biology of the Cell ( I2BC) – University Paris-Saclay, CEA, CNRS, Gif-sur-Yvette (France)

Group II Intron Splicing and its Implications for Spliceosomal Splicing

Franck Dequiedt, PhD

University of Liege, Liège (Belgium)

Perturbations of the cellular splicing landscape by oncogenic transcription factors

Pablo Vivas-Mejia, PhD

University of Puerto Rico Medical Sciences, San Juan (Porto Rico)

Increased expression of the RBPMS splice variants inhibit cell proliferation in ovarian cancer cells

Jianfei Hu, PhD

Head of Genomics Analysis Core Vaccine Research Center National Institutes of Health, Maryland (USA)

Stochastic Principles Governing Alternative Splicing of RNA

Christoph Winkler, PhD

Department of Biological Sciences National University of Singapore (Singapore)

Srsf6b-induced splicing defects contribute to selective motor neuron vulnerability in a zebrafish model for Spinal Muscular Atrophy